Navin Fluorine International Limited · NSE:NAVINFLUOR

Navin Fluorine International — Q1 FY2016 Earnings Presentation

18 slides from Navin Fluorine International's earnings presentation, 2015

1. Slide 1: Result Update Presentation Q1 FY16

   Navin Fluorine International Limited Result Update Presentation Q1 FY16

2. Slide 2: Safe Harbor

   Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Navin Fluorine International Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe

3. Slide 3: Key Performance Highlights – Q1FY16

   Key Performance Highlights – Q1FY16 Rs.Crs Revenue EBITDA & EBITDA Margin 30 20% +16% 17% 25  Revenue growth 15% 20 across business units 15 9% 10% driven by: 150 26 130 10 5%  Higher volumes 5 12 0 0%  Better realizations Q1FY15 Q1FY16 Q1FY15 Q1FY16  Margins expanded mainly on account of Operat

4. Slide 4: Business Units Performance: Refrigerants and Inorganic Fluorides

   Business Units Performance Refrigerants Inorganic Fluorides Revenue (Rs.Crs) 59 61 26 28 27 25 24 50 49 36 Q1FY15 Q2FY15 Q3FY15 Q4FY15 Q1FY16 Q1FY15 Q2FY15 Q3FY15 Q4FY15 Q1FY16 Exports Geographic Mix – Q1FY15 13% Exports 41% Domestic 59% Domestic 87% 4

5. Slide 5: Business Units Performance: Specialty Chemicals and CRAMS

   Business Units Performance Specialty Chemicals CRAMS Revenue (Rs.Crs) 59 57 16 55 55 45 10 8 4 4 Q1FY15 Q2FY15 Q3FY15 Q4FY15 Q1FY16 Q1FY15 Q2FY15 Q3FY15 Q4FY15 Q1FY16 Domestic 0% Geographic Mix – Q1FY15 Exports 45% Exports 100% Domestic 55% 5

6. Slide 6: On-Going Capex

   On-Going Capex  Greenfield Facility at Dahej, Gujarat.  JV with Piramal Enterprises Ltd. (PEL)  Facility to develop, manufacture and sell speciality Fluorochemicals for healthcare segment  Current estimates of investments ~Rs.140 Crs  Expected to come on-stream by H2FY16  Manufacturing Facilit

7. Slide 7: Standalone Profitability Statement

   Standalone Profitability Statement Rs. Crs. Q1 FY16 Q1 FY15 Change % FY15 Revenue 150 130 16% 546 Raw Material 71 65 272 Employee Expenses 16 17 61 Other Expenses 38 36 150 EBITDA 26 12 109% 63 EBITDA Margin 17.0% 9.4% 11.6% Interest Expenses 0.5 0.2 3.2 Depreciation 4.5 4.5 18.6 Operating PBT 20.6

8. Slide 8: Business Overview

   Responsible Care” Business Overview rN Wh ARVIND MAFATLAL GROUP

9. Slide 9: Overview

   Overview Building “India’s only plant with high pressure fluorination capabilities with Largest Integrated Specialty cGMP compliance” for CRAMS Business Fluorochemical Company in India Manufacturing plants Over 45 years of expertise strategically located in Handling Fluorine closer to major ports St

10. Slide 10: Business Units (BU) - Standalone

    Business Units (BU) - Standalone FY11 – Revenue % FY15 – Revenue % Commenced CRAMS business in 2011 CRAMS – 0% CRAMS – 6% Commenced Specialty Chemicals in Specialty Specialty 2000 Chemicals – 27% Chemicals –39% Inorganic Fluorides & Inorganic Inorganic Refrigerants are Fluorides – 18% Fluorides –19%

11. Slide 11: Clients across the Globe

    & e Clients across the Globe Ne ; UJ CLARIANT™ Cs) Bayer syngenta Cs) Bayer CropScience 2. PHARMACEUTICAL anaadl Bem. —_INDUSTRIESLTD. eo LUPIN AUROBINDO ‘Committed to Healthier Life e ae Y Dr.ReDpy's LIFE. RESEARCH . HOPE IN: i ARVIND MAFATLAL GROUP

12. Slide 12: Key Strengths

    Key Strengths Fluorination Capabilities In-house R&D  Pioneered Manufacturing of  State-of-the-art R&D centre – Navin Refrigerant Gases in India Research Innovation Centre at Surat  Over 45 years of experience in  DSIR approved R&D Centre handling Fluorine  Supports in product addition &  Exte

13. Slide 13: Growth driven by Every Business Unit

    Growth driven by Every Business Unit CRAMS  Business progression from Contract research to contract manufacturing  Manufacturing facility to be operational from H1FY16 Specialty Chemicals  Introduction of new high value added molecules in portfolio  Entry into newer geographies Inorganic Fluorid

14. Slide 14: Historical Financial Data

    Historical Financial Data 14

15. Slide 15: Consolidated Profitability Statement

    Consolidated Profitability Statement Rs. Crs. FY15 FY14 Change % Revenue 592 486 22% Raw Material 289 228 Employee Expenses 74 59 Other Expenses 156 133 EBITDA 72 66 9.4% EBITDA Margin 12.2% 13.6% Interest Expenses 3 6 Depreciation 20 22 Operating PBT 49 39 26% Operating PBT Margin 8.24% 7.94% Other

16. Slide 16: Consolidated Balance Sheet

    Consolidated Balance Sheet Rs. Crs. Mar’15 Mar’14 Shareholder’s Fund Share capital 10 10 Reserves & Surplus 578 546 Minority Interest 13 9 Non-current liabilities Long term borrowings 27 - Deferred Tax Liabilities (net) 32 33 Other non-current liabilities 28 28 Current liabilities Short term borrowi

17. Slide 17: Dividend History

    Dividend History Dividend Per Share (Rs.) Consistent Dividend Payout  Continuous Dividend 15% 21% 32% 33% 31% 32% since last 10 years 75  Special Dividend of Rs. 60 per share in FY 12 16 16 15 15  Payout Ratio of more 14 than 30% in last 4 years  Declared Total dividend of Rs.16 per share in FY1

18. Slide 18: Contact

    Contact For further information, please contact: Company : Investor Relations Advisors : Navin Fluorine International Ltd. Strategic Growth Advisors Pvt. Ltd. CIN : L24110MH1998PLC115499 CIN : U74140MH2010PTC204285 Mr. Sitendu Nagchaudhuri Ms. Sanjita Ghosh / Mr. Shogun Jain Chief Financial Officer

Navin Fluorine International — Q1 FY2016 Earnings Presentation on 6ix